Invention Publication
- Patent Title: HSD17B13 INHIBITORS AND/OR DEGRADERS
-
Application No.: US18482129Application Date: 2023-10-06
-
Publication No.: US20240150334A1Publication Date: 2024-05-09
- Inventor: Jan Antoinette Cusi Romero Adams , Bruce Michael Bechle , Jason Kenneth Dutra , Michelle Renee Garnsey , Xinjun Hou , Jisun Lee , Deane Milford Nason, II , Steven Victor O'Neil , Danica Antonia Rankic , Yang Wang , Ann Sorrentino Wright , Lei Zhang , Liying Zhang , David James Edmonds
- Applicant: Pfizer Inc.
- Applicant Address: US NY New York
- Assignee: Pfizer Inc.
- Current Assignee: Pfizer Inc.
- Current Assignee Address: US NY New York
- Main IPC: C07D413/04
- IPC: C07D413/04 ; C07D231/56 ; C07D263/56 ; C07D401/04 ; C07D403/04 ; C07D405/14 ; C07D413/14 ; C07D417/04 ; C07D471/04 ; C07D487/04 ; C07D491/048 ; C07D498/04 ; C07D513/04
Abstract:
Described herein are compounds of Formula I,
wherein the variables are defined herein, their use as HSD17B13 inhibitors and/or degraders, pharmaceutical compositions containing such compounds and their use to treat, for example, NAFLD and NASH.
wherein the variables are defined herein, their use as HSD17B13 inhibitors and/or degraders, pharmaceutical compositions containing such compounds and their use to treat, for example, NAFLD and NASH.
Information query
